FAQ

Semaglutide Frequently Asked Questions

Semaglutide, the active ingredient in Ozempic®, is FDA-approved for weight loss. Initially developed for type 2 diabetes to lower blood sugar, it was found to aid in weight loss by:

– Lowering blood sugar through insulin production, regulating insulin, and converting carbohydrates into energy instead of fat.

– Decreasing appetite by mimicking the GLP-1 hormone, signaling fullness sooner.

– Prolonging fullness by slowing gastric emptying.

Yes, semaglutide is FDA-approved for weight loss, initially used for type 2 diabetes. It lowers blood sugar, decreases appetite, and prolongs fullness by mimicking the GLP-1 hormone.

Patients can lose significant weight by lowering blood sugar, decreasing appetite, and prolonging fullness.

No, semaglutide is approved for weight loss and was initially for type 2 diabetes to lower blood sugar and reduce appetite.

The duration depends on individual goals and medical advice. It works by lowering blood sugar, decreasing appetite, and prolonging fullness.

Semaglutide, the active ingredient in Ozempic® (our most commonly recommended medication), is injected weekly, which helps lower blood sugar, reduce appetite, and prolong fullness